Emerging molecular markers of cancer

Sidransky, David·2002·Nature Reviews Cancer

Cited by (656)

Items 101–200 of 656

  1. Salivary Markers for Oral Cancer Detection
    Anastasios K. Markopoulos, Evangelia Z. Michailidou, Georgios Tzimagiorgis · 2010 · The Open Dentistry Journal
  2. Proteomics‐based identification of α‐enolase as a tumor antigen in non‐small lung cancer
    Ping He, Tetsuji Naka, Satoshi Serada, Minoru Fujimoto, Toshio Tanaka, Shoji Hashimoto, Yoshihito Shima, Tomoki Yamadori, Hidekazu Suzuki, Tomonori Hirashima et al. · 2007 · Cancer Science
  3. Salivary Biomarkers for Clinical Applications
    Lei Zhang, Hua Xiao, David T. Wong · 2009 · Molecular Diagnosis & Therapy
  4. Estrogen Receptor-α Methylation Predicts Melanoma Progression
    Takuji Mori, Steve R. Martinez, Steven J O'Day, Donald L. Morton, Naoyuki Umetani, Minoru Kitago, Atsushi Tanemura, Sandy L. Nguyen, Andy N. Tran, He-Jing Wang et al. · 2006 · Cancer Research
  5. Mutation Detection by Real-Time PCR: A Simple, Robust and Highly Selective Method
    John Morlan, Joffre B. Baker, Dominick V. Sinicropi · 2009 · PLoS ONE
  6. Cancer epigenetics: above and beyond
    Mariana Brait, David Sidransky · 2011 · Toxicology Mechanisms and Methods
  7. Recovering circulating extracellular or cell-free RNA from bodily fluids
    Georgios Tzimagiorgis, Evangelia Z. Michailidou, Aristeidis Κritis, Anastasios K. Markopoulos, Sofia Kouidou · 2011 · Cancer Epidemiology
  8. Methylation as a biomarker for head and neck cancer
    Lídia Maria Rebolho Batista Arantes, Ana Carolina de Carvalho, Matias Eliseo Melendez, André Lopes Carvalho, Eny Maria Goloni‐Bertollo · 2014 · Oral Oncology
  9. Ice -COLD-PCR enables rapid amplification and robust enrichment for low-abundance unknown DNA mutations
    Coren A. Milbury, Jin Li, Gerassimos Mike Makrigiorgos · 2010 · Nucleic Acids Research
  10. Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer
    Ming Shan, Huizi Yin, Junnan Li, Xiaobo Li, Dong Wang, Yonghui Su, Ming Niu, Zhenbin Zhong, Ji Wang, Xianyu Zhang et al. · 2016 · Oncotarget
  11. Rapid Identification and Quantification of Tumor Cells Using an Electrocatalytic Method Based on Gold Nanoparticles
    Alfredo de la Escosura‐Muñiz, Christian Sánchez‐Espinel, Belén Díaz-Freitas, África González‐Fernández, Marisa Maltez‐da Costa, Arben Merkoçi · 2009 · Analytical Chemistry
  12. Disruptive TP53 Mutation Is Associated with Aggressive Disease Characteristics in an Orthotopic Murine Model of Oral Tongue Cancer
    Daisuke Sano, Tong‐Xin Xie, Thomas Julian Ow, Mei Zhao, Curtis R. Pickering, Ge Zhou, Vlad Constantin Sandulache, David A. Wheeler, Richard A. Gibbs, Carlos Caulı́n et al. · 2011 · Clinical Cancer Research
  13. Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients
    Peta E. Jackson · 2003 · Carcinogenesis
  14. Epigenetic biomarkers in urological tumors: A systematic review
    Cármen Jerónimo, Rui Henrique · 2011 · Cancer Letters
  15. Quantitative assessment of DNA methylation: potential applications for disease diagnosis, classification, and prognosis in clinical settings
    Romulo Martin Brena, Tim H.‐M. Huang, Christoph Plass · 2006 · Journal of Molecular Medicine
  16. Epigenetic Inactivation of ID4 in Colorectal Carcinomas Correlates with Poor Differentiation and Unfavorable Prognosis
    Naoyuki Umetani, Hiroya Takeuchi, Akihide Fujimoto, Masaru Shinozaki, Anton J. Bilchik, Dave S.�B. Hoon · 2004 · Clinical Cancer Research
  17. Association of Circulating Tumor Cells with Serum Tumor-Related Methylated DNA in Peripheral Blood of Melanoma Patients
    Kazuo Koyanagi, Takuji Mori, Steven J O'Day, Steve R. Martinez, He-Jing Wang, Dave S.�B. Hoon · 2006 · Cancer Research
  18. Epigenetic Inactivation of Tumor Suppressor Genes in Serum of Patients with Cutaneous Melanoma
    Alessandra Marini, Alireza Mirmohammadsadegh, Sandeep Nambiar, Annett Gustrau, Thomas Ruzicka, Ulrich R. Hengge · 2005 · Journal of Investigative Dermatology
  19. Progress in determining the malignant potential of oral lesions
    Crispian M. Scully, Jon Sudbø, Paul Michael Speight · 2003 · Journal of Oral Pathology and Medicine
  20. Protein Profiling of Microdissected Pancreas Carcinoma and Identification of HSP27 as a Potential Serum Marker
    Christian Melle, Günther Ernst, Niko Escher, Daniel Hartmann, Bettina Schimmel, Annett Bleul, Heike Thieme, Roland Kaufmann, Klaus Felix, Helmut Frieß et al. · 2007 · Clinical Chemistry
  21. A Proteomics Analysis of Cell Signaling Alterations in Colorectal Cancer
    Juan Madoz‐Gúrpide, Marta Cañamero, Lydia Sánchez, José Solano, Patricia Alfonso, José Ignacio Casal · 2007 · Molecular & Cellular Proteomics
  22. Cell-based sensor for analysis of EGFR biomarker expression in oral cancer
    Shannon E. Weigum, Pierre N. Floriano, Nicolaos J. Christodoulides, John T. McDevitt · 2007 · Lab on a Chip
  23. Optical protein sensor for detecting cancer markers in saliva
    Winny Tan, Leyla Sabet, Yang Li, Tianwei Yu, Perry R. Klokkevold, David T. Wong, Chih‐Ming Ho · 2008 · Biosensors and Bioelectronics
  24. Proteomic analysis of cancer-cell mitochondria
    Mukesh Verma, Jacob Kagan, David Sidransky, Sudhir Srivastava · 2003 · Nature reviews. Cancer
  25. Towards a simple, saliva-based test for the detection of oral cancer.
    David T. Wong · 2006 · Expert Review of Molecular Diagnostics
  26. Demethylation of Urokinase Promoter as a Prognostic Marker in Patients with Breast Carcinoma
    Pouya Pakneshan, Bernard Têtu, Shafaat Ahmed Rabbani · 2004 · Clinical Cancer Research
  27. Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma
    Chang Do Jee, Min A Kim, Eun Ji Jung, Jin‐Man Kim, Woo Ho Kim · 2009 · European Journal of Cancer
  28. Nanodevices in diagnostics
    Ye Hu, Daniel H. Fine, Ennio Tasciotti, Ali Bouamrani, Mauro Ferrari B · 2010 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
  29. Surface-Enhanced Raman Scattering Based Ligase Detection Reaction
    Yun Suk Huh, Adam J. Lowe, Aaron D. Strickland, Carl A. Batt, David Erickson · 2009 · Journal of the American Chemical Society
  30. Detection of Mutant Free Circulating Tumor DNA in the Plasma of Patients with Gastrointestinal Stromal Tumor Harboring Activating Mutations of CKIT or PDGFRA
    Jacqueline Maier, Thoralf Lange, Irina A. Kerle, Katja Specht, Melanie Bruegel, Claudia Wickenhauser, Philipp Jakob Jost, Dietger W. Niederwieser, Christian Peschel, Justus Duyster et al. · 2013 · Clinical Cancer Research
  31. DNA‐Templated Assembly of a Heterobivalent Quantum Dot Nanoprobe For Extra‐ and Intracellular Dual‐Targeting and Imaging of Live Cancer Cells
    Wei Wei, Xuewen He, Nan Ma · 2014 · Angewandte Chemie International Edition
  32. Pathway-Based Biomarker Search by High-Throughput Proteomics Profiling of Secretomes
    Kevin Lawlor, Arpi Nazarian, Lynne Lacomis, Paul Tempst, Josep Villanueva · 2009 · Journal of Proteome Research
  33. Protein biomarker discovery for head and neck cancer
    Tieneke B.M. Schaaij‐Visser, Ruud H. Brakenhoff, Charles René Leemans, Albert J. R. Heck, Monique Slijper · 2010 · Journal of Proteomics
  34. Electrochemical stripping analysis of nanogold label-induced silver deposition for ultrasensitive multiplexed detection of tumor markers
    Guosong Lai, Lili Wang, Jie Wu, Huangxian Ju, Feng Yan · 2012 · Analytica Chimica Acta
  35. Increased Plasma Circulating Cell-Free DNA Could Be a Potential Marker for Oral Cancer
    Li-Han Lin, Kuo‐Wei Chang, Shou‐Yen Kao, Hui-Wen Cheng, Chung‐Ji Liu · 2018 · International Journal of Molecular Sciences
  36. Application of a methylation gene panel by quantitative PCR for lung cancers
    Narayan Shivapurkar, Victor Stastny, Makoto Suzuki, Ignacio Ivan Wistuba, Lin Li, Yingye Zheng, Ziding Feng, Bernard E. A. Hol, Clemens Prinsen, Erik Thunnissen et al. · 2006 · Cancer Letters
  37. Global Methylation Pattern of Genes in Androgen-Sensitive and Androgen-Independent Prostate Cancer Cells
    Dhruva Kumar Mishra, Zujian Chen, Yanyuan Wu, Marianna Sarkissyan, Harold Phillip Koeffler, Jaydutt V. Vadgama · 2010 · Molecular Cancer Therapeutics
  38. Peroxiredoxin‐I is an autoimmunogenic tumor antigen in non‐small cell lung cancer
    Jong Wook Chang, Seung Hee Lee, Ju Yeon Jeong, Ho Zoon Chae, Young Chul Kim, Zee‐Yong Park, Yung Joon Yoo · 2005 · FEBS Letters
  39. Oral squamous cell carcinoma: Key clinical questions, biomarker discovery, and the role of proteomics
    Uzma Urooj Malik, Shamshad Zarina, Stephen R. Pennington · 2015 · Archives of Oral Biology
  40. Gene methylation and early detection of genitourinary cancer: the road ahead
    Paul Cairns · 2007 · Nature reviews. Cancer
  41. A Sequence-specific Exopeptidase Activity Test (SSEAT) for “Functional” Biomarker Discovery
    Josep Villanueva, Arpi Nazarian, Kevin Lawlor, San San Yi, Richard J. Robbins, Paul Tempst · 2007 · Molecular & Cellular Proteomics
  42. Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients
    Lomnytska, Marta, Dubrovska, Anna, Hellman, Ulf, Volodko, Natalya, Souchelnytskyi, Serhiy · 2006 · International Journal of Cancer
  43. A microarray platform for detecting disease-specific circulating miRNA in human serum
    Somenath Roy, Jun Hui Soh, Jackie Y. Ying · 2015 · Biosensors and Bioelectronics
  44. Colorimetric multiplexed immunoassay for sequential detection of tumor markers
    Jing Wang, Ya Cao, Yuanyuan Xu, Genxi Li · 2009 · Biosensors and Bioelectronics
  45. Liquid biopsy of HPV DNA in cervical cancer
    Tak Hong Cheung, So Fan Yim, Mei Yun Yu, Michael J. Worley, Stephen J. Fiascone, Rossa W. K. Chiu, Keith W.K. Lo, Nelson S.S. Siu, Martin C. S. Wong, Apple C. M. Yeung et al. · 2019 · Journal of Clinical Virology
  46. Unconventional Secretion is a Major Contributor of Cancer Cell Line Secretomes
    Laura Villarreal, Olga Méndez, Cándida Salvans, Josep Gregori, Jose M Baselga, Josep Villanueva · 2012 · Molecular & Cellular Proteomics
  47. Aberrant Promoter Methylation of Multiple Genes during Pathogenesis of Bladder Cancer
    Mariana Brait, Shahnaz Begum, André Lopes Carvalho, Santanu Dasgupta, Andre Luiz Vettore, Bogdan A. Czerniak, Otávia L. Caballero, William H. Westra, David Sidransky, Mohammad Obaidul Hoque · 2008 · Cancer Epidemiology Biomarkers & Prevention
  48. GSH-Activated NIR Fluorescent Prodrug for Podophyllotoxin Delivery
    Yajing Liu, Shaojia Zhu, Kaizhi Gu, Zhiqian Guo, Xiaoyu Huang, Mingwei Wang, Hesham M. Amin, Weihong Zhu, Ping Shi · 2017 · ACS Applied Materials & Interfaces
  49. Assessing the Use of p16INK4a Promoter Gene Methylation in Serum for Detection of Bladder Cancer
    M Valenzuela · 2002 · European Urology
  50. Continuous microfluidic 3D focusing enabling microflow cytometry for single-cell analysis
    Sheng Yan, Dan Yuan · 2020 · Talanta
  51. miR-365 Promotes Cutaneous Squamous Cell Carcinoma (CSCC) through Targeting Nuclear Factor I/B (NFIB)
    Meijuan Zhou, Liang Zhou, Zheng Li, Ling Guo, Yinghui Wang, Hongxia Liu, Chengshan Ou, Zhenhua Ding · 2014 · PLoS ONE
  52. Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: Potential prognostic marker and target for tumourigenicity-suppression
    Youqiang Ke, Paul Smith, Carol Beesley, Michihiro Igarashi, Hiroshi Fujii, Shiva S. Forootan, Janet Adamson, Christopher S. Foster, Elwin Morgan · 2008 · International Journal of Oncology
  53. Detecting cancer by monitoring circulating tumor DNA
    Paul T. Spellman, Joe W. Gray · 2014 · Nature Medicine
  54. Optical Imaging in Cancer Research: Basic Principles, Tumor Detection, and Therapeutic Monitoring
    Metasebya Solomon, Yang Liu, Mikhail Y. Berezin, Samuel A. Achilefu · 2011 · Medical Principles and Practice
  55. Detection of gene promoter hypermethylation in fine needle washings from breast lesions.
    Cármen Jerónimo, Isabel Costa, Maria C. Martins, Paula Monteiro, Susana Lisboa, Carlos Palmeira, Rui Henrique, Manuel Rodrigues Teixeira, Carlos Lopes · 2003 · PubMed
  56. Serum Protein MALDI Profiling to Distinguish Upper Aerodigestive Tract Cancer Patients From Control Subjects
    David Sidransky · 2003 · JNCI Journal of the National Cancer Institute
  57. Emerging nanoproteomics approaches for disease biomarker detection: A current perspective
    Sandipan Ray, Panga Jaipal Reddy, Sandeep Choudhary, Dinesh Raghu, Sanjeeva Srivastava · 2011 · Journal of Proteomics
  58. Performance of mitochondrial DNA mutations detecting early stage cancer
    John P. Jakupciak, Samantha Maragh, Maura E. Markowitz, Alissa K. Greenberg, Mohammad Obaidul Hoque, Anirban Maitra, Peter E. Barker, Paul Daniel Wagner, William N. Rom, Sudhir Srivastava et al. · 2008 · BMC Cancer
  59. Ultrasensitive Detection of DNA and RNA Based on Enzyme-Free Click Chemical Ligation Chain Reaction on Dispersed Gold Nanoparticles
    Daiki Kato, Motoi Oishi · 2014 · ACS Nano
  60. Automated serum peptide profiling
    Josep Villanueva, Kevin Lawlor, Ricardo Toledo‐Crow, Paul Tempst · 2006 · Nature Protocols
  61. Frequent Methylation ofEyes Absent 4Gene in Barrett's Esophagus and Esophageal Adenocarcinoma
    Hongzhi Zou, Neal K. Osborn, Jonathan J. Harrington, Kristie K. Klatt, Julian R. Molina, Lawrence J. Burgart, David A. Ahlquist · 2005 · Cancer Epidemiology Biomarkers & Prevention
  62. Mitochondrial-targeted penetrating peptide delivery for cancer therapy
    Jiao Wu, Jason Li, Hu Wang, Chang-Bai Liu · 2018 · Expert Opinion on Drug Delivery
  63. Hyper-methylation of ABCG1 as an epigenetics biomarker in non-small cell lung cancer
    Thi-Oanh Tran, Luu Ho Thanh Lam, Nguyen Quoc Khanh Le · 2023 · Functional & Integrative Genomics
  64. DNA methylation-based biomarkers in serum of patients with breast cancer
    Lien Van De Voorde, Reinhart Speeckaert, Dirk Van Gestel, Marc Bracke, Wilfried De Neve, Joris Delanghe, Marijn M. Speeckaert · 2012 · Mutation Research/Reviews in Mutation Research
  65. IgH gene rearrangements as plasma biomarkers in Non-Hodgkin's Lymphoma patients
    Jian He, Jian Wu, Yuchen Jiao, Nina D. Wagner‐Johnston, Richard F. Ambinder, Luis Alberto Diaz, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos · 2011 · Oncotarget
  66. Epigenetic Modifications of RASSF1A Gene through Chromatin Remodeling in Prostate Cancer
    Ken Kawamoto, Steven T. Okino, Robert F. Place, Shinji Urakami, Hiroshi Hirata, Nobuyuki Kikuno, Toshifumi Kawakami, Yuichiro Tanaka, Deepa Pookot, Zhong Chen et al. · 2007 · Clinical Cancer Research
  67. Single living cell detection of telomerase over-expression for cancer detection by an optical fiber nanobiosensor
    Xin Ting Zheng, Chang Ming Li · 2009 · Biosensors and Bioelectronics
  68. Linear combination methods to improve diagnostic/prognostic accuracy on future observations
    Le Kang, Aiyi Liu, Lili Tian · 2013 · Statistical Methods in Medical Research
  69. Recent Progress in Aptamer‐Based Functional Probes for Bioanalysis and Biomedicine
    Huimin Zhang, Leiji Zhou, Zhi Zhu, Chaoyong James Yang · 2016 · Chemistry - A European Journal
  70. Metabolic Profiling of Total Physical Activity and Sedentary Behavior in Community-Dwelling Men
    Kota Fukai, Sei Harada, Miho Iida, Ayako Kurihara, Ayano Takeuchi, Kazuyo Kuwabara, Daisuke Sugiyama, Tomonori Okamura, Miki Onishi Akiyama, Yuji Nishiwaki et al. · 2016 · PLoS ONE
  71. Quantitative hypermethylation of NMDAR2B in human gastric cancer
    Junwei Liu, Myoung Sook Kim, Jatin Kumar Nagpal, Keishi Yamashita, Maria Luana Poeta, Xiaofei Chang, Juna Lee, Hannah Lui Park, Cármen Jerónimo, William H. Westra et al. · 2007 · International Journal of Cancer
  72. Multimodality Fusion Aspects of Medical Diagnosis: A Comprehensive Review
    Sachin Kumar, Sita Rani, Shivani Sharma, Hong Min · 2024 · Bioengineering
  73. Nanogold/mesoporous carbon foam-mediated silver enhancement for graphene-enhanced electrochemical immunosensing of carcinoembryonic antigen
    Dajie Lin, Jie Wu, Huangxian Ju, Feng Yan · 2013 · Biosensors and Bioelectronics
  74. Promise and Challenge: Markers of Prostate Cancer Detection, Diagnosis and Prognosis
    Dean A. Troyer, James N. Mubiru, Robin J. Leach, Susan L. Naylor · 2004 · Disease Markers
  75. AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma
    Takeshi Namiki, Atsushi Tanemura, Julio C. Valencia, Sergio G. Coelho, Thierry Passeron, Masakazu Kawaguchi, Wilfred D. Vieira, Masashi Ishikawa, Wataru Nishijima, Toshiyuki Izumo et al. · 2011 · Proceedings of the National Academy of Sciences
  76. Translating genomic biomarkers into clinically useful diagnostics
    Geoffrey S. Ginsburg, Susanne B. Haga · 2006 · Expert Review of Molecular Diagnostics
  77. Characterization of Pepsinogen C as a Potential Biomarker for Gastric Cancer Using a Histo-Proteomic Approach
    Christian Melle, Günther Ernst, Bettina Schimmel, Annett Bleul, Roland Kaufmann, Merten Hommann, Konrad Klaus Richter, Wolfgang Daffner, Utz Settmacher, Uwe Claussen et al. · 2005 · Journal of Proteome Research
  78. Integral Protein Microarrays for the Identification of Lung Cancer Antigens in Sera That Induce a Humoral Immune Response
    Juan Madoz‐Gúrpide, Rork D. Kuick, Hong Wang, David E. Misek, Samir Hanash · 2007 · Molecular & Cellular Proteomics
  79. Remodeling Tumor Microenvironment by Multifunctional Nanoassemblies for Enhanced Photodynamic Cancer Therapy
    Chen Liang, Xinglin Zhang, Mengsu Yang, Wenjun Wang, Peng Chen, Xiaochen Dong · 2020 · ACS Materials Letters
  80. Tissue Inhibitor of Metalloproteinases-3 Promoter Methylation is an Independent Prognostic Factor for Bladder Cancer
    Mohammad Obaidul Hoque, Shahnaz Begum, Mariana Brait, Cármen Jerónimo, MARIANNA L. ZAHURAK, Kimberly Laskie Ostrow, Eli Rosenbaum, Bruce J. Trock, William H. Westra, Mark Schoenberg et al. · 2007 · The Journal of Urology
  81. Development and Use of Biomarkers in Oncology Drug Development
    Eugenia Floyd, Teresa M. McShane · 2004 · Toxicologic Pathology
  82. DNA Degradation Test Predicts Success in Whole-Genome Amplification from Diverse Clinical Samples
    Fengfei Wang, Lilin Wang, Christine E. Briggs, Ewa Sicińska, Sandra Marlene Gaston, Harvey J. Mamon, Matthew H. Kulke, Raffaella Zamponi, Massimo F. Loda, Elizabeth Anne Maher et al. · 2007 · Journal of Molecular Diagnostics
  83. NMR of hyperpolarised probes
    Christopher Witte, Leif Schröder · 2012 · NMR in Biomedicine
  84. Cytosine Methylation Profiles as a Molecular Marker in Non–Small Cell Lung Cancer
    Mathias Ehrich, John K. Field, Triantafillos Liloglou, George Xinarianos, Paul Oeth, Matthew R. Nelson, Charles R. Cantor, Dirk van den Boom · 2006 · Cancer Research
  85. Plasma/serum proteomics: pre-analytical issues
    Stefano Barelli, David Crettaz, Lynne Thadikkaran, Olivier Rubin, Jean‐Daniel Tissot · 2007 · Expert Review of Proteomics
  86. Advances in breast cancer diagnosis: a comprehensive review of imaging, biosensors, and emerging wearable technologies
    Abdul Qayyum Khan, Manahil Touseeq, Sara Rehman, Maria Tahir, Malaika Ashfaq, Emaan Jaffar, Saadullah Farooq Abbasi · 2025 · Frontiers in Oncology
  87. Inactivation of RASSF1A tumor suppressor gene by aberrant promoter hypermethylation in human pituitary adenomas
    Zhi Rong Qian, Toshiaki Sano, Katsuhiko Yoshimoto, Shozo Yamada, Akira Ishizuka, Noriko Mizusawa, Hidehisa Horiguchi, Mitsuyoshi Hirokawa, Sylvia L. Asa · 2005 · Laboratory Investigation
  88. Searching for molecular markers in head and neck squamous cell carcinomas (HNSCC) by statistical and bioinformatic analysis of larynx-derived SAGE libraries
    Nelson José Freitas da Silveira, Leonardo Varuzza, Ariane Machado‐Lima, Marcelo de Souza Lauretto, Daniel Guariz Pinheiro, Rodrigo V. Rodrigues, Patrícia Severino, Francisco G. Nóbrega, Head and Neck Genome Project GENCAPO, Wilson A. Silva et al. · 2008 · BMC Medical Genomics
  89. Quantitative Detection of Promoter Hypermethylation as a Biomarker of Acute Kidney Injury During Transplantation
    Tulsi Mehta, Mohammad Obaidul Hoque, Richard M. Ugarte, M.H. Rahman, Edward S. Kraus, Robert A. Montgomery, Keith P Melancon, David Sidransky, Hamid Rabb · 2006 · Transplantation Proceedings
  90. Electrochemical immunosensor based on hyperbranched structure for carcinoembryonic antigen detection
    Jingjing Miao, Xiaobo Wang, Liandi Lu, Peiyuan Zhu, Chun Mao, Haolin Zhao, Youchao Song, Jian Shen · 2014 · Biosensors and Bioelectronics
  91. Is serum level of methylated RASSF1A valuable in diagnosing hepatocellular carcinoma in patients with chronic viral hepatitis C?
    Nadia Mohamed, Eman M. Swify, Nabila F. Amin, Mona M. Soliman, Lubna M. Tag-Eldin, Nahla M. Elsherbiny · 2012 · Arab Journal of Gastroenterology
  92. Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions
    Cármen Jerónimo, Paula Monteiro, Rui Henrique, Mário Jorge Dinis-Ribeiro, Isabel Costa, Vera L. Costa, Luísa Filipe, André Lopes Carvalho, Mohammad Obaidul Hoque, Irene Pais et al. · 2007 · Breast Cancer Research and Treatment
  93. Utilizing the Molecular Gateway: The Path to Personalized Cancer Management
    Jonathan B. Overdevest, Dan Theodorescu, Jae K. Lee · 2009 · Clinical Chemistry
  94. Integration of nanomaterials with nucleic acid amplification approaches for biosensing
    Ziyue Wang, Peng Li, Lin Cui, Jian‐Ge Qiu, Bing‐Hua Jiang, Chun‐yang Zhang · 2020 · TrAC Trends in Analytical Chemistry
  95. Flexible combination of multiple diagnostic biomarkers to improve diagnostic accuracy
    Tu Xu, Yixin Fang, Alan Rong, Junhui Wang · 2015 · BMC Medical Research Methodology
  96. Liquid Biopsy Applications in the Clinic
    Dake Chen, Tao Xu, Shubin Wang, Howard Chang, Tao Yu, Yu Zhu, Jian Chen · 2020 · Molecular Diagnosis & Therapy
  97. Proteomic technology for biomarker profiling in cancer: an update
    Moulay A. Alaoui‐Jamali, Yingjie Xu · 2006 · Journal of Zhejiang University SCIENCE B
  98. Identification of Novel Epigenetic Markers for Clear Cell Renal Cell Carcinoma
    Gul S. Dalgin, Michele Drever, Tara Williams, Thomas Charles King, Charles DeLisi, Louis S. Liou · 2008 · The Journal of Urology
  99. Digital quantification of mutant DNA in cancer patients
    Frank Diehl, Luis Alberto Diaz · 2006 · Current Opinion in Oncology
  100. Overexpression of Metastasis-Associated Protein 1 is Significantly Correlated with Tumor Angiogenesis and Poor Survival in Patients with Early-Stage Non-Small Cell Lung Cancer
    Shuhai Li, Hui Tian, Weiming Yue, Lin Li, Wenjun Li, Zhitao Chen, Wensi Hu, Yingchao Zhu, Lei Qi · 2011 · Annals of Surgical Oncology